nih-gov/heal.nih.gov/funding/awarded/export?combine=1R44GM140795-01A1&page&_format=csv

"Project #","Project Title","Research Focus Area","Research Program","Administering IC(s)",Institution(s),Investigator(s),Location(s),"Year Awarded",Summary
1R44GM140795-01A1,"Non-Opioid Post-Operative Pain Management Using Bupivacaine-loaded Poly(ester urea) Mesh","Cross-Cutting Research","Small Business Programs",NIGMS,"21MEDTECH, LLC","ALFARO, ARTHUR","Durham, NC",2021,"There is an urgent need for non-opioid post-operative pain management solutions.  This research is developing a naturally absorbable polymer film that can release controlled amounts of the non-opioid analgesic bupivacaine – aiming to manage pain for several days following surgery. Project objectives are to optimize the timing of drug release, develop manufacturing standards, determine effective dosage for preserving motor function, and determine safety and efficacy in mouse models of neuropathic pain. Continued development of this film delivery system may lead to a new, non-opioid therapeutic strategy that could be combined with local anesthesia for up to 4 days after surgery to reduce or potentially eliminate opioids use."
		`"Project #","Project Title","Research Focus Area","Research Program","Administering IC(s)",Institution(s),Investigator(s),Location(s),"Year Awarded",Summary`
		1R44GM140795-01A1,"Non-Opioid Post-Operative Pain Management Using Bupivacaine-loaded Poly(ester urea) Mesh","Cross-Cutting Research","Small Business Programs",NIGMS,"21MEDTECH, LLC","ALFARO, ARTHUR","Durham, NC",2021,"There is an urgent need for non-opioid post-operative pain management solutions. This research is developing a naturally absorbable polymer film that can release controlled amounts of the non-opioid analgesic bupivacaine – aiming to manage pain for several days following surgery. Project objectives are to optimize the timing of drug release, develop manufacturing standards, determine effective dosage for preserving motor function, and determine safety and efficacy in mouse models of neuropathic pain. Continued development of this film delivery system may lead to a new, non-opioid therapeutic strategy that could be combined with local anesthesia for up to 4 days after surgery to reduce or potentially eliminate opioids use."